Related Experiment Video
Updated: May 20, 2025

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Dravet syndrome: Insights into seizure and speech progression from registry data
Margaux Delporte1, Johan Verbeeck2, Isabella Brambilla3
1KU Leuven, L-BioStat, Kapucijnenvoer 7, 3000 Leuven, Belgium; Weill Cornell Medicine, Cornell University, 1300 York Ave, New York 10065 NY, United States.
Objective:
Dravet syndrome (DS) is a rare genetic developmental and epileptic encephalopathy syndrome characterized by refractory seizures and neurodevelopmental disorders beginning in infancy. This study aims to understand the natural history of DS by utilizing longitudinal data from patient registries.
Methods:
We analysed data from 475 subjects across two European patient registries (RESIDRAS and Platform-RESIDRAS) from Dravet Italia Onlus, collected between 2010 and 2024. The study included only participants that were under 18 years old. Clinical characteristics such as seizure types and speech development were modelled using generalized linear mixed models and ordinal transition models.
Results:
Unilateral seizures predominantly occurred during infancy and early childhood, while generalized convulsive and focal to bilateral tonic-clonic seizures increased with age, showing a higher incidence in boys. Focal seizures peaked around the age of three years before declining. Speech development varied, with most participants initially having poor speech. However, a considerable number of transitions between different levels of speech impairment were observed over time. Transition models indicated that once speech is acquired, the likelihood of losing this ability is negligible.
Significance:
Patient registries are instrumental in modelling the disease history of DS, offering insight into its progression by means of advanced statistical modelling techniques that build on clinical expertise. Future research should focus on evaluating the effects of therapies and exploring the interrelations between different clinical characteristics. Understanding these aspects can guide better management strategies and improve patient outcomes.
More Related Videos
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
05:54Stereo-Electro-Encephalo-Graphy SEEG With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note
Published on: June 13, 2016
Related Concept Videos
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Arteries of the Lower Limbs
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...